Amgen Oncology(@AmgenOncology) 's Twitter Profileg
Amgen Oncology done

@AmgenOncology

Advancing All Angles of Care. Tweets intended for U.S. audience. See our Community Guidelines: https://t.co/WUbqtYa6KT.

ID:1012121021711728640

linkhttp://amgenoncology.com calendar_today27-06-2018 23:50:30

2,4K Tweets

66,5K Followers

153 Following

Follow People
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

We’ll be cheering on our Amgen 🧪🔬🧬 team on Nov 5 at LUNGevity Foundation’s Breathe Deep TOGETHER annual walk to help people live longer, fuller lives with . Join us in Chicago, DC, NYC, Kingston, PA, Boston, or anywhere!

account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

When Laurie learned about her specific type of , she discovered a targeted treatment option that made a difference in her journey. Read her inspiring story in this recent article in @People: bit.ly/3UlWyj0

When Laurie learned about her specific type of #lungcancer, she discovered a targeted treatment option that made a difference in her journey. Read her inspiring story in this recent #AmgenSponsored article in @People: bit.ly/3UlWyj0 #LCAM
account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

Every lung cancer is different and understanding what makes each diagnosis unique can help guide the best path forward. During , join us in raising awareness about the importance of biomarker testing throughout a person’s cancer care journey.

account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

Every lung cancer is different, and understanding your unique diagnosis can help determine your care options. As starts tomorrow, join us to learn how testing can help people with non-small cell lung cancer navigate their treatment journey.

account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

As nears, we continue to highlight the importance of comprehensive biomarker testing. Listen in as Amgen 🧪🔬🧬’s Dr. Byeong Yoon explains why people living with non-small cell lung cancer ( ) should know their status.

account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

Thank you, The Galien Foundation, for this award honoring Amgen 🧪🔬🧬 oncology innovation. Scientific breakthroughs are the product of collaboration, and we’re grateful that many years of hard work, research, and discovery have opened up new treatment possibilities for people with cancer.

account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

Thanks to everyone who attended Amgen 🧪🔬🧬 Oncology’s first-ever Social Media Summit! We know that no one person or company has all the answers, but together we can find new ways to address barriers to cancer care & achieve health equity.

account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

Tune in at 12pm ET today to hear from Amgen 🧪🔬🧬’s Greg Friberg about advances for patients with solid tumor cancers during this The Galien Foundation webinar. Amgen is a nominee for our first-in-class targeted medicine for non-small cell lung cancer (NSCLC): bit.ly/3sw0d1x

account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

We’re live at Amgen 🧪🔬🧬 Oncology’s inaugural Educational Summit! Influential voices committed to have joined us to explore how we can work together to ensure people going through receive the best possible care. Follow along for more!

account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

As acute lymphoblastic leukemia (ALL) treatment rapidly evolves, assessing measurable residual disease (MRD) status in patients can play an important role in their care. Learn more in this CAPathologists webinar with Rashmi Kanagal-Shamanna, MD.

account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

We might not have special powers, but there is power in unity, and it is up to all of us to recognize & apply our unique capabilities when . What makes you a superhero?

account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

When treating patients with acute lymphoblastic leukemia (ALL), a concise and easy-to-interpret summary of measurable residual disease (MRD) assessments over time provides key data that can be used to guide next steps in treatment planning.

account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

We’ve been selected as a 2022 nominee for driving innovation to improve human health. Thank you to The Galien Foundation for this honor. We look forward to the awards ceremony taking place on Oct. 27 in NYC!

account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

Advanced practice providers (APPs) are often involved in every aspect of testing for patients with non-small cell lung cancer ( ). Learn more about the key role APPs play in this crucial part of treatment planning: bit.ly/3vH5aGO

account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

Patients inspire all we do, and we’re honored to walk alongside blood cancer survivors & supporters to with The Leukemia & Lymphoma Society. Click through to see our team at this weekend’s Gold Coast event, an uplifting evening filled with light, music & hope.

account_circle
Amgen Oncology(@AmgenOncology) 's Twitter Profile Photo

The CDC Foundation’s Empowered Health Ambassadors have one thing in common: experience with cancer. During , learn how these healthcare professionals, caregivers & patients have empowered themselves and others through their journey with breast cancer.

account_circle